Chi-Cheng Li , Director

我要掛號 Doctor Code:25007

Special Expertise

  • Hematopoietic stem cell transplantation
  • High resolution flow cytometry in the detection of minimal residual disease & diagnosis of myelodysplastic syndrome

Current position

  • Director, Center of Stem Cells and Precision Medicine , Hualien Tzu Chi Hospital

Education

  • Bachelor of Medicine, China Medical College
  • Master of Science, Biomedical Engineering, National Cheng Kung University

Experience

  • Medical officer in army service
  • Residency in Internal Medicine, Buddhist Tzu Chi GeneralHospital
  • Received medical license from the Internal Medicine Society of Taiwan
  • Visiting Physician, Sloan-Kettering Cancer Center, New York, USA
  • Fellow, Department of Hematology and Oncology, National Taiwan University Hospital, Taiwan
  • Received medical license from the Hematology Society of Taiwan
  • Attending physician, Department of Hematology and Oncology, Buddhist Tzu Chi General Hospital
  • Received medical license from the Chinese Oncology Society
  • Visiting physician at Department of Hematopoietic Stem cell Transplantation, Fred Hutchinson Cancer Research Center, Seattle, USA
  • Instructor, Medical School, Buddhist Tzu Chi University 
  • Director, Hematopoietic Stem Cell Transplantation Center, Buddhist Tzu Chi General Hospital
  • Attending physician, Section of Hematology-Oncology, Department of Internal Medicine, National Taiwan University Hospital
  • Attending physician, National Taiwan University Tai Cheng Stem Cell Therapy Center
  •  Secretary General, The Hematology Society of Taiwan

Membership

  • Member, Chinese Society of Internal Medicine, Taiwan
  • Member, Chinese Society of Hematology, Taiwan
  • Member, Chinese Society of Cancer, Taiwan
  • Member, Chinese Society of Bone Marrow Transplantation, Taiwan
  • Member, Taiwanese Society of Molecular Medicine
  • Member, American Society of Hematology

Publications

  1. Win KT, Liau JY, Chen BJ, Takata K, Chen CY, *Li CC, Hsiao CH, Chuang SS. Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis. Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):105-11. doi: 10.1097/PAI.0000000000000162.
     
  2. Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, Lin CT, *Li CC, Wu SJ, Hou HA, Chou WC, Huang SY, Tsay W, Chen YC, Chen YC, Chang SC, Ko BS, Tien HF. High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan. PLoS One. 2015 Jun 10;10(6):e0128410. doi: 10.1371/journal.pone.0128410. eCollection 2015.
     
  3. Cheng CL, *Li CC, Hou HA, Fang WQ, Chang CH, Lin CT, Tang JL, Chou WC, Chen CY, Yao M, Huang SY, Ko BS, Wu SJ, Tsay W, Tien HF. Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. BMC Cancer. 2015 May 2;15:344. doi: 10.1186/s12885-015-1376-9.
     
  4. Hou HA, Chou WC, Kuo YY, Liu CY, Lin LI, Tseng MH, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, *Li CC, Huang SY, Ko BS, Hsu SC, Chen CY, Lin CT, Wu SJ, Tsay W, Chen YC, Tien HF. TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution. Blood Cancer J. 2015 Jul 31;5:e331. doi: 10.1038/bcj.2015.59.
     
  5. Hou HA, Liu CY, Kuo YY, Chou WC, Tsai CH, Lin CC, Lin LI, Tseng MH, Chiang YC,Liu MC, Liu CW, Tang JL, Yao M, *Li CC, Huang SY, Ko BS, Hsu SC, Chen CY, Lin CT, Wu SJ, Tsay W, Tien HF. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget. 2016 Feb 23;7(8):9084-101. doi: 10.18632/oncotarget.7000.
     
  6. Chiang Y, Tsai CH, Kuo SH, Liu CY, Yao M, *Li CC, Huang SY, Ko BS, Lin CT, Hou HA, Chou WC, Liu JH, Lin CC, Wu SJ, Hsu SC, Chen YC, Lin KH, Lin DT, Chou HT, Lu MY, Yang YL, Chang HH, Liu MC, Liao XW, Wu JK, Chou SC, Cheng CL, Chen CY, Tsay W, Tien HF, Tang JL, Chen YH. Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation. Sci Rep. 2016 Nov 10;6:36730. doi: 10.1038/srep36730.

 

Copyright © 2024 花蓮慈濟醫學中心. 版權所有. 地址:花蓮市中央路三段707號 連絡電話:03-8561825 .